Genomic and oncoproteomic advances in detection and treatment of colorectal cancer

World Journal of Surgical Oncology

Volumn 7, Issue , 2009, Pages

  McHugh, Seamus M ^a   O'Donnell, Jill ^a   Gillen, Peter ^a  

^a OUR LADY OF LOURDES HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; TUMOR MARKER; TUMOR PROTEIN;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER TISSUE; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ISOLATION; GENOMICS; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LABORATORY TEST; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUTROPENIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; CHEMISTRY; COLORECTAL TUMOR; DNA METHYLATION; GENETICS; MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

COLORECTAL NEOPLASMS; DNA METHYLATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENOMICS; HUMANS; NEOPLASM PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 65449144811     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-7-36     Document Type: Review

References (81)

1. Madoz-Gurpide J Cañamero M Sanchez L Solano J Alfonso P Casal JI A proteomic analysis of cell signalling alterations in colorectal cancer Molecular & Cellular Proteomics 2007, 6(12):2150-64 10.1074/ mcp.M700006-MCP200
2. Cho WS Contribution of oncoproteomics to cancer biomarker discovery Molecular Cancer 2007, 6:25 1852117 17407558 10.1186/1476-4598-6-25
3. Kim SY Hahn WC Cancer genomics: Integrating form and function Carcinogenesis 2007, 28(7):1387-1392 10.1093/carcin/bgm086 17434922
4. Kim H-Y Yu MH Kim H Byun J Lee C Noninvasive molecular biomarkers for the detection of colorectal cancer BMB reports 2008, 41(10):685-692 http://www.jbmb.or.kr/jbmb/jbmb_files/ %5B41-10%5D0810290852_(685-692)BMB148(Lee).pdf 18959813
5. Atkin W Options for screening for colorectal cancer Scand J Gastroenterol 2003, 237(Suppl):13-16 10.1080/00855910310001421
6. Hundt S Haug U Brenner H Blood markers for early detection of colorectal cancer: A systematic review Cancer Epidemiol Biomarkers Prev 2007, 16(10):1935-53 10.1158/1055-9965.EPI-06-0994 17932341
7. Cho WS Oncoproteomics: Current trends and future perspectives Expert Rev Proteomics 2007, 4(3):401-410 10.1586/14789450.4.3.401 17552924
8. Duffy MJ van Dalen A Haglund C Hansson L Holinski-Feder E Klapdor R Lamerz R Peltomaki P Sturgeon C Topolcan O Tumour markers in colorectal cancer: European group on tumour markers (EGTM) guidelines for clinical use Eur J Cancer 2007, 43(9):1348-60 10.1016/j.ejca.2007.03.021 17512720
9. Alvarado MD Jensen EH Yeatman TJ The potential role of gene expression in the management of primary and metastatic colorectal cancer Cancer Control 2006, 13:27-31 16508623
10. Gal R Sadikov E Sulkes J Klein B Koren R Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients Dis Colon Rectum 2004, 47(7):1216-24 10.1007/s10350-004-0552-9 15148649
11. des Guetz G Mariani P Cucherousset J Benamoun M Lagorce C Sastre X Le Toumelin P Uzzan B Perret GY Morere JF et al Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer Anticancer Res 2007, 27(4C):2715-19 17695437
12. Bertolini F Bengala C Losi L Pagano M Iachetta F Dealis C Jovic G Depenni R Zironi S Falchi AM et al Prognostic and predictive value of baseline and post treatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy Int J Radiat Oncol Biol Phys 2007, 68(5):1455-61 17445998
13. Mariadason JM Arango D Shi Q Wilson AJ Corner GA Nicholas C Aranes MJ Lesser M Schwartz EL Augenlicht LH Gene expression profiling-based prediction of response of colon carcinoma cells to 5-Fluorouracil and Camptothecin Cancer Research 2003, 63:8791-8812 14695196
14. Peters GJ van Groeningen CJ Laurensse EJ Pinedo HM A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa Cancer 1991, 68:1903-1909 10.1002/ 1097-0142(19911101)68:9<1903::AID-CNCR2820680910>3.0.CO;2-9 1717130
15. Kinoshita M Kodera Y Hibi K Nakayama G Inoue T Ohashi N Ito Y Koike M Fujiwara M Nakao A Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: Potential as predictive parameters for response to fluorouracil-based chemotherapy Anticancer Res 2007, 27(2):851-6 17465211
16. Yamada H Iinuma H Watanabe T Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy Oncol Rep 2008, 19(3):729-35 18288408
17. Del Rio M Molina F Bascoul-Mollevi C Copois V Bibeau F Chalbos P Bareil C Kramar A Salvetat N Fraslon C Conseiller E et al Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of Leucovorin, Fluorouracil, and Irinotecan J Clin Oncol 2007, 25:773-80 2257989 17327601 10.1200/JCO.2006.07.4187
18. Jung JJ Jeung HC Lee JO Kim TS Chung HC Rha SY Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents Oncol Rep 2007, 18(3):593-9 17671706
19. Shimizu D Ishikawa T Ichikawa Y Togo S Hayasizaki Y Okazaki Y Danenberg PV Shimada H Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays Int J Oncol 2005, 27(2):371-6 16010417
20. Matsuyama R Togo S Shimizu D Momiyama N Ishikawa T Ichikawa Y Endo I Kunisaki C Suzuki H Hayasizaki Y Shimada H Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: Three-gene expression model predicts clinical response Int J Cancer 2006, 119(2):406-13 10.1002/ijc.21843 16477629
21. Palomaki GE Bradley LA Douglas MP Kolor K Dotson WD Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review Genet Med 2009, 11(1):21-34 19125129
22. Watanabe T Komuro Y Kiyomatsu T Kanazawa T Kazama Y Tanaka J Tanaka T Yamamoto Y Shirane M Muto T et al Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles Cancer Research 2006, 66:3370-3374 10.1158/0008-5472.CAN-05-3834 16585155
23. Ojima E Inoue Y Miki C Mori M Kusunoki M Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy J Gastroenterol 2007, 42(9):730-6 10.1007/ s00535-007-2089-x 17876542
24. Kim IJ Lim SB Kang HC Chang HJ Ahn SA Park HW Jang SG Park JH Kim DY Jung KH et al Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer Dis Colon Rectum 2007, 50(9):1342-53 10.1007/ s10350-007-277-7 17665260
25. Dworak O Keilholz L Hoffmann A Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 1997, 12:19-23 10.1007/s003840050072 9112145
26. Rimkus C Friederichs J Boulesteix AL Theisen J Mages J Becker K Nekarda H Rosenberg R Janssen KP Siewert JR Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer Clin Gastroenterol Hepatol 2008, 6(1):53-61 10.1016/j.cgh.2007.10.022 18166477
27. Hardcastle JD Chamberlain JO Robinson MH Moss SM Amar SS Balfour TW James PD Mangham CM Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 1996, 348:1467-71 10.1016/ S0140-6736(96)03386-7 8942774
28. Iacopetta B TP53 mutation in colorectal cancer Hum Mutat 2003, 21:271-276 10.1002/humu.10175 12619112
29. Suzuki H Gabrielson E Chen W Ambazhagan R van Engeland M Weijenberg MP Herman JG Baylin SB A genomic screen forgenes upregulated by demethylation and histone deacetylase inhibitionin human colorectal cancer Nature Genetics 2002, 31(2):141-9 31 10.1038/ng892 11992124
30. Deng G Kakar S Tanaka H Matsuzaki K Miura S Sleisenger MH Kim YS Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics Eur J Cancer 2008, 44(9):1290-1301 10.1016/j.ejca.2008.03.014 18486467
31. Deng G Kakar S Okudiara K Choi E Sleisenger MH Kim YS Unique methylation pattern of oncostatin M receptor gene in cancers of colorectum and other digestive organs Clin Cancer Res 2009, 15(5):1519-26 10.1158/ 1078-0432.CCR-08-1778 19223499
32. Yamashita K Dai T Dai Y Yamamoto F Perucho M Genetics supersedes epigenetics in colon cancer phenotype Cancer cell 2003, 4:121-131 10.1016/S1535-6108(03)00190-9 12957287
33. O'Neal J Gao F Hassan A Monahan R Barrios S Lee I Chnq WJ Vij R Tomasson MH Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma Exp Hematol 2009, 37(2):234-244 10.1016/j.exphem.2008.10.014 19135901
34. de Noo ME Tollenaar RA Deelder AM Bouwman LH Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears World J Gastroenterol 2006, 12(41):6594-6601 17075970
35. Sanchez J-C Corthals GL Hochstrasser DF Biomedical applications of proteomics Wiley-VCH 1 2004
36. Smith L Lind MJ Welham KJ Cawkwell L Cancer proteomics and its application to discovery of therapy response markers in human cancer Cancer 2006, 107(2):232-41 10.1002/cncr.22000 16752413
37. Shen DW Cardarelli C Hwang J Cornwell M Richert N Ishii S Pastan I Gottesman MM Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins J Biol Chem 1986, 261(17):7762-70 3711108
38. Ji H Reid GE Moritz RL Eddes JS Burgess AW Simpson RJ A two-dimensional gel database of human colon carcinoma proteins Electrophoresis 1997, 18(3-4):605-13 10.1002/elps.1150180344 9150948
39. Tomonaga T Matsushita K Yamaguchi S Oh-Ishi M Kodera Y Maeda T Shimada H Ochiai T Nomura F Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis Clinical Cancer Res 2004, 10(6):2007-14 10.1158/1078-0432.CCR-03-0321
40. Stulík J Hernychová L Porkertová S Knízek J Macela A Bures J Jandik P Langridge JI Jungblut PR Proteome study of colorectal carcinogenesis Electrophoresis 2001, 22(14):3019-25 10.1002/ 1522-2683(200108)22:14<3019::AID-ELPS3019>3.0.CO;2-T 11565796
41. Jungblut PR Zimny-Arndt U Zeindl-Eberhart E Stulik J Koupilova K Pleissner KP Otto A Müller EC Sokolowska-Köhler W Grabher G et al Proteomics in human disease: Cancer, heart and infectious diseases Electrophoresis 1999, 20(10):2100-10 10.1002/ (SICI)1522-2683(19990701)20:10<2100::AID-ELPS2100>3.0.CO;2-D 10451122
42. Stulík J Koupilova K Osterreicher J Knízek J Macela A Bures J Jandík P Langr F Dedic K Jungblut PR Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma Electrophoresis 1999, 20(18):3638-46 10.1002/ (SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0.CO;2-W 10612291
43. Xing XM Wang YH Huang Q Lü BJ Lai MD Differential expression of secretagogin and glucose-related protein 78 in colorectal cancer: A proteome study Zhonghua Bing Li Xue Za Zhi 2007, 36(2):107-12 17493385
44. Adolf K Wagner L Bergh A Stattin P Ottosen P Borre M Birkenkamp-Demtröder K Orntoft TF Tørring N Secretagogin is a new neuroendocrine marker in the human prostate Prostate 2007, 6(5):472-84 10.1002/pros.20523 17285592
45. Desiderio DM Zhan X The human pituitary proteome: The characterization of differentially expressed proteins in an adenoma compared to a control Cell Mol Biol (Noisy-le-grand) 2003, 49:689-712 14528906
46. Wagner L Oliyarnyk O Gartner W Nowotny P Groeger M Kaserer K Waldhäusl W Pasternack MS Cloning and expression of secretagogin, a novel neuroendocrine - and pancreatic islet of Langerhans - specific Ca2+ binding protein J Biol Chem 2000, 275(32):24740-51 10.1074/ jbc.M001974200 10811645
47. Birkenkamp-Demtröder K Wagner L Brandt Sørensen F Bording Astrup L Gartner W Scherübl H Heine B Christiansen P Ørntoft TF Secretagogin is a novel marker for neuroendocrine differentiation Neuroendocrinology 2005, 82(2):121-38 10.1159/000091207 16449819
48. Bi X Lin Q Foo TW Joshi S You T Shen HM Ong CN Cheah PY Eu KW Hew CL Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways Mol Cell Proteomics 2006, 5(6):1119-30 10.1074/ mcp.M500432-MCP200 16554294
49. Unwin RD Craven RA Harnden P Hanrahan S Totty N Knowles M Eardley I Selby PJ Banks RE Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect Proteomics 2003, 3(8):1620-1632 10.1002/pmic.200300464 12923786
50. Xu RH Pelicano H Zhou Y Carew JS Feng L Bhalla KN Keating MJ Huang P Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res 2005, 65(2):613-21 15695406
51. Zu XL Guppy M Cancer metabolism: Facts, fantasy, and fiction Biochem Biophys Res Commun 2004, 313(3):459-65 10.1016/j.bbrc.2003.11.136 14697210
52. Alfonso P Núñez A Madoz-Gurpide J Lombardia L Sánchez L Casal JI Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis Proteomics 2005, 5(10):2602-11 10.1002/pmic.200401196 15924290
53. de Noo ME Mertens BJ Ozalp A Bladergroen MR Werff van der MP Velde van de CJ Deelder AM Tollenaar RA Detection of colorectal cancer using MALDI-TOF serum protein profiling Eur J Cancer 2006, 42(8):1068-76 10.1016/j.ejca.2005.12.023 16603345
54. Zhao L Liu L Wang S Zhang YF Yu L Ding YQ Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins J Cancer Res Clin Oncol 2007, 133(10):771-82 10.1007/ s00432-007-0222-0 17503081
55. Morino M Tsuzuki T Ishikawa Y Shirakami T Yoshimura M Kiyosuke Y Matsunaga K Yoshikumi C Saijo N Specific expression of HSP27 in human tumor cell lines in vitro In Vivo 1997, 11(2):179-84 9179613
56. Garrido C Fromentin A Bonnotte B Favre N Moutet M Arrigo AP Mehlen P Solary E Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones Cancer Res 1998, 58(23):5495-9 9850085
57. Hadaschik BA Jackson J Fazli L Zoubeidi A Burt HM Gleave ME So AI Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer BJU Int 2008, 102(5):610-6 10.1111/j.1464-410X.2008.07669.x 18384625
58. Kamada M So A Muramaki M Rocchi P Beraldi E Gleave M Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells Mol Cancer Ther 2007, 6(1):299-308 10.1158/1535-7163.MCT-06-0417 17218637
59. Choi DH Ha JS Lee WH Song JK Kim GY Park JH Cha HJ Lee BJ Park JW Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells FEBS Lett 2007, 581(8):1649-56 10.1016/ j.febslet.2007.02.075 17395183
60. Liu L Wu DH Ding YQ Tiam1 gene expression and its significance in colorectal carcinoma World J Gastroenterol 2005, 11(5):705-7 15655826
61. Liu L Zhao L Zhang Y Zhang Q Ding Y Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer Cell Biol Int 2007, 31(8):805-14 10.1016/ j.cellbi.2007.01.014 17376711
62. Engwegen JY Helgason HH Cats A Harris N Bonfrer JM Schellens JH Beijnen JH Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry World J Gastroenterol 2006, 12(10):1536-44 16570345
63. Gulmann C Sheehan KM Kay EW Liotta LA Petricoin EFM 3rd Array-based proteomics: Mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer J Pathol 2006, 208(5):595-606 10.1002/ path.1958 16518808
64. Liu XP Shen J Li ZF Yan L Gu J A serum proteomicpattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionisation time spectrometry Cancer Invest 2006, 24(8):747-53 10.1080/07357900601063873 17162557
65. Seibert V Ebert MP Buschmann T Advances in clinical cancer proteomics: SELDI-TOF-mass spectrometry and biomarker discovery Brief Funct Genomic Proteomic 2005, 4(1):16-26 10.1093/bfgp/4.1.16 15975261
66. Smith FM Gallagher WM Fox E Stephens RB Rexhepaj E Petricoin EF 3rd Liotta L Kennedy MJ Reynolds JV Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy Ann Surg 2007, 245(2):259-66 1876990 17245180 10.1097/01.sla.0000245577.68151.bd
67. Zhang J-T Liu Y Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment Cancer Treat Rev 2007, 33(8):741-56 2203306 17854999 10.1016/j.ctrv.2007.07.018
68. Zimmermann U Balabanov S Giebel J Teller S Junker H Schmoll D Protzel C Scharf C Kleist B Walther R Increased expression and altered location of annexin IV in renal clear cell carcinoma: A possible role in tumour dissemination Cancer Lett 2004, 209(1): 111-8 10.1016/ j.canlet.2003.12.002 15145526
69. Yee DS Narula N Ramzy I Boker J Ahlering TE Skarecky DW Ornstein DK Reduced anexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer Arch Pathol Lab Med 2007, 131(6):902-8 17550317
70. Perathoner A Pirkebner D Brandacher G Spizzo G Stadlmann S Obrist P Margreiter R Amberger A 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients Clin Cancer Res 2005, 11(9):3274-9 10.1158/1078-0432.CCR-04-2207 15867223
71. Liu Y Liu H Han B Zhang JT Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis Cancer Res 2006, 66(6):3248-55 10.1158/ 0008-5472.CAN-05-3801 16540677
72. Sinha P Hütter G Köttgen E Dietel M Schadendorf D Lage H Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas Electrophoresis 1999, 20(14):2952-60 10.1002/ (SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H 10546833
73. Kitteringham NR Jenkins RE Lane CS Elliott VL Park BK Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics Journal of Chromatography B 2008
74. Whiteaker JR Zhang H Zhao L Wang P Kelly-Spratt KS Ivey RG Piening BD Feng LC Kasarda E Gurley KE et al Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer J Proteome Res 2007, 6(10):3962-75 10.1021/pr070202v 17711321
75. Nicol GR Han M Kim J Birse CE Brand E Nguyen A Mesri M FitzHugh W Kaminker P Moore PA et al Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients Mol Cell Proteomics 2008, 7(10):1974-82 10.1074/mcp.M700476-MCP200 18388126
76. Mischak H Coon JJ Novak J Weissinger EM Schanstra JP Dominiczak AF Capillary electrophoresis-mass spectrometry asa powerful tool in biomarker discovery and clinical diagnosis: Anupdate of recent developments Mass Spectrom Rev 2008 18973238
77. Perry RH Cooks RG Noll RJ Orbitrap mass spectrometry: Instrumentation, ion motion and applications Mass Spectrom Rev 2008, 27(6):661-99 10.1002/ mas.20186 18683895
78. Ye X Blonder J Veenstra TD Targeted proteomics for validation of biomarkers in clinical samples Brief Funct Genomic Proteomic 2008 19109305
79. Pignone M Saha S Hoerger T Mandelblatt J Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the U.S. preventative services task force Ann Intern Med 2002, 137(2):96-104 12118964
80. Pepe MS Cai T Longton G Combining predictors for classification using the area under the receiver operating characteristic curve Biometrics 2006, 62(1):221-9 10.1111/j.1541-0420.2005.00420.x 16542249
81. Bast RC Jr Lilja H Urban N Rimm DL Fritsche H Gray J Veltri R Klee G Allen A Kim N et al Translational crossroads for biomarkers Clin Cancer Res 2005, 11(17):6103-8 10.1158/1078-0432.CCR-04-2213 16144908